Our Health Economics division provides data-driven analyses that empower policymakers, healthcare professionals, employers, and stakeholders to make informed decisions that promote better health outcomes and optimize resource allocation.
Our Capabilities:
Comprehensive economic analyses across diverse health conditions and treatment modalities
❤️ Cardiometabolic DiseasesCost-benefit analyses of obesity interventions, lipoprotein(a) screening economics, cardiovascular risk assessment, diabetes management costs, and emerging therapy evaluations |
🎗️ CancersCancer treatment cost trajectories, novel therapy economics, patient burden assessments, and healthcare resource utilization across tumor types |
🦠 Infectious DiseasesAntimicrobial resistance economic burden, infectious disease treatment costs, and prevention program ROI |
🥗 Lifestyle InterventionNutritional intervention economics, behavioral program effectiveness, food security impact on health costs, and dietary policy outcomes |
Access national and sub-regional data for your specific market
Explore additional GlobalData health intelligence portals
|
💊
PharmaceuticalsDrug pricing, market access, reimbursement analysis, and pharmaceutical policy insights, including reports and published studies available for download. |
📈
Pharma TrendsEmerging pharmaceutical trends, pipeline intelligence, and market forecasting across therapeutic areas, with access to reports and published studies. |
🩺
Healthcare WorkforceWorkforce supply and demand analysis, staffing economics, and health system capacity planning, supported by reports and published research studies. |